CompuGroup Medical Confirms Organic Revenue Growth Outlook

CompuGroup Medical SE & Co. KGaA confirmed its ambition to achieve an organic year-on-year revenue growth of 5% and more per year from 2021 through 2025.

In addition, the company has now also adopted targets for the medium-term increase in adjusted EBITDA margin for the first time. Accordingly, It aims to increase the adjusted EBITDA margin to approximately 25% in 2023 and to about 27% in 2025.

The company confirmed the full year 2021 guidance. It expects revenues in 2021 to be in a range of 1 billion euros and 1.04 billion euros as well as adjusted EBITDA between 210 million euros and 230 million euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT